Stem Cell Therapy, Ophthalmic Applications, and the Current Controversies With Direct-to-Consumer Marketing.

Suppr

超能文献

作者信息

Hwang Jodi C, Staropoli Patrick C, Kuriyan Ajay E, Yannuzzi Nicolas A, Sridhar Jayanth

出版信息

Int Ophthalmol Clin. 2020 Fall;60(4):179-192. doi: 10.1097/IIO.0000000000000329.

DOI:10.1097/IIO.0000000000000329

PMID:33093325

Abstract

摘要

相似文献

Stem Cell Therapy, Ophthalmic Applications, and the Current Controversies With Direct-to-Consumer Marketing.

Int Ophthalmol Clin. 2020 Fall;60(4):179-192. doi: 10.1097/IIO.0000000000000329.

High Stakes: Direct to Consumer Marketing of Unproven Stem Cell Treatments for Lung Disease.

Chest. 2018 Jun;153(6):1294-1295. doi: 10.1016/j.chest.2018.01.051.

Direct-to-consumer marketing of stem cell interventions by Canadian businesses.

Regen Med. 2018 Sep;13(6):643-658. doi: 10.2217/rme-2018-0033. Epub 2018 Sep 26.

Industry Responsibilities in Tackling Direct-to-Consumer Marketing of Unproven Stem Cell Treatments.

Clin Pharmacol Ther. 2017 Aug;102(2):177-179. doi: 10.1002/cpt.704. Epub 2017 Jul 10.

Stem Cell Joint Therapy: Promising, but Not Ready for Prime Time.

Am J Nurs. 2019 Dec;119(12):16-17. doi: 10.1097/01.NAJ.0000615744.47010.6a.

The direct-to-consumer market for stem cell-based interventions in Australia: exploring the experiences of patients.

Regen Med. 2020 Jan;15(1):1238-1249. doi: 10.2217/rme-2019-0089. Epub 2020 Feb 3.

Stem cell clinics: risk of proliferation.

Lancet Oncol. 2020 Feb;21(2):205-206. doi: 10.1016/S1470-2045(19)30787-9.

Assessing "Cell Therapy" Clinics Offering Treatments of Ocular Conditions using Direct-to-Consumer Marketing Websites in the United States.

Ophthalmology. 2019 Oct;126(10):1350-1355. doi: 10.1016/j.ophtha.2019.03.019. Epub 2019 Mar 21.

Rogue stem cell clinics.

Bone Joint J. 2020 Feb;102-B(2):148-154. doi: 10.1302/0301-620X.102B2.BJJ-2019-1104.R1.

Crowdfunding for Unproven Stem Cell-Based Interventions.

JAMA. 2018 May 8;319(18):1935-1936. doi: 10.1001/jama.2018.3057.

引用本文的文献

Interaction Between Mesenchymal Stem Cells and Retinal Degenerative Microenvironment.

Front Neurosci. 2021 Jan 21;14:617377. doi: 10.3389/fnins.2020.617377. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Stem Cell Therapy, Ophthalmic Applications, and the Current Controversies With Direct-to-Consumer Marketing.

Int Ophthalmol Clin. 2020 Fall;60(4):179-192. doi: 10.1097/IIO.0000000000000329.

High Stakes: Direct to Consumer Marketing of Unproven Stem Cell Treatments for Lung Disease.

Chest. 2018 Jun;153(6):1294-1295. doi: 10.1016/j.chest.2018.01.051.

Direct-to-consumer marketing of stem cell interventions by Canadian businesses.

Regen Med. 2018 Sep;13(6):643-658. doi: 10.2217/rme-2018-0033. Epub 2018 Sep 26.

Industry Responsibilities in Tackling Direct-to-Consumer Marketing of Unproven Stem Cell Treatments.

Clin Pharmacol Ther. 2017 Aug;102(2):177-179. doi: 10.1002/cpt.704. Epub 2017 Jul 10.

Stem Cell Joint Therapy: Promising, but Not Ready for Prime Time.

Am J Nurs. 2019 Dec;119(12):16-17. doi: 10.1097/01.NAJ.0000615744.47010.6a.

The direct-to-consumer market for stem cell-based interventions in Australia: exploring the experiences of patients.

Regen Med. 2020 Jan;15(1):1238-1249. doi: 10.2217/rme-2019-0089. Epub 2020 Feb 3.

Stem cell clinics: risk of proliferation.

Lancet Oncol. 2020 Feb;21(2):205-206. doi: 10.1016/S1470-2045(19)30787-9.

Assessing "Cell Therapy" Clinics Offering Treatments of Ocular Conditions using Direct-to-Consumer Marketing Websites in the United States.

Ophthalmology. 2019 Oct;126(10):1350-1355. doi: 10.1016/j.ophtha.2019.03.019. Epub 2019 Mar 21.

Rogue stem cell clinics.

Bone Joint J. 2020 Feb;102-B(2):148-154. doi: 10.1302/0301-620X.102B2.BJJ-2019-1104.R1.

Crowdfunding for Unproven Stem Cell-Based Interventions.

JAMA. 2018 May 8;319(18):1935-1936. doi: 10.1001/jama.2018.3057.

引用本文的文献

Interaction Between Mesenchymal Stem Cells and Retinal Degenerative Microenvironment.

Front Neurosci. 2021 Jan 21;14:617377. doi: 10.3389/fnins.2020.617377. eCollection 2020.